The European Patent Office (EPO) has officially granted patent EP3587561B1, titled "DEVICE AND METHOD FOR SEPARATING MOBILE CELLS." This patent, with an effective date of March 18, 2026, covers specific technologies related to cell separation and purification, as indicated by its IPC classifications including C12N 5/076 and A61B 17/425. The designated states include a broad range of European countries.

This grant represents a new intellectual property right for the inventor and any associated entities. While not a regulatory mandate in the traditional sense, it establishes exclusive rights for the use of the patented technology within the designated European states. Companies operating in the biotechnology, pharmaceutical, or medical device sectors, particularly those involved in cell-based therapies or diagnostics, should review this patent to ensure they do not infringe on the granted claims. No immediate compliance actions are required for entities not directly using this specific patented technology, but awareness is advised for potential licensing or development considerations.